Metabolic associated fatty liver disease and bone mineral density: a cross-sectional study of the National Health and Nutrition Examination Survey 2017

Metabolic associated fatty liver disease and bone mineral density: a cross-sectional study of the National Health and Nutrition Examination Survey 2017–2018

Published:2023-01-31 Issue:4 Volume:34 Page:713-724
ISSN:0937-941X
Container-title:Osteoporosis International
language:en
Short-container-title:Osteoporos Int

Author:

Liu Jinmin,Tang Yuchen,Feng Zhiwei,Chen Yi,Zhang Xiaohui,Xia Yayi,Geng Bin

Funder

National Natural Science Foundation of China

Cuiying Scientific and Technological Innovation Program of Lanzhou University Second Hospital

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism

Link

https://link.springer.com/content/pdf/10.1007/s00198-023-06687-w.pdf

Reference48 articles.

1. Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M (2016) Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 64(1):73–84

2. Cotter TG, Rinella M (2020) Nonalcoholic fatty liver disease 2020: the state of the disease. Gastroenterology 158(7):1851–1864

3. Ciardullo S, Perseghin G (2021) Prevalence of NAFLD, MAFLD and associated advanced fibrosis in the contemporary United States population. Liver Int 41(6):1290–1293

4. Younossi ZM (2019) Non-alcoholic fatty liver disease — a global public health perspective. J Hepatol 70(3):531–544

5. Eslam M, Newsome PN, Sarin SK, Anstee QM, Targher G, Romero-Gomez M, Zelber-Sagi S, Wai-Sun Wong V, Dufour JF, Schattenberg JM et al (2020) A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J Hepatol 73(1):202–209

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In vitro osteoclast differentiation enhanced by hepatocyte supernatants from high-fat diet mice;Biochemistry and Biophysics Reports;2024-09

2. Metabolic dysfunction–associated fatty liver disease and osteoporosis: the mechanisms and roles of adiposity;Osteoporosis International;2024-08-13

3. The association of waist circumference with bone mineral density and risk of osteoporosis in US adult: National health and nutrition examination survey;Bone;2024-08

4. Anti-osteoporotic treatments in the era of non-alcoholic fatty liver disease: friend or foe;Frontiers in Endocrinology;2024-03-08

5. The relationship between advanced liver fibrosis and osteoporosis in type 2 diabetes patients with MAFLD;Endocrine;2024-02-17